nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HTR2A—Gilles de la Tourette syndrome	0.914	1	CbGaD
Donepezil—ACHE—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0089	0.153	CbGpPWpGaD
Donepezil—Tetrabenazine—DRD2—Gilles de la Tourette syndrome	0.00824	1	CrCbGaD
Donepezil—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00512	0.0881	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00439	0.0755	CbGpPWpGaD
Donepezil—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00391	0.2	CbGeAlD
Donepezil—HRH3—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00353	0.0607	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00315	0.0541	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00305	0.0526	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00285	0.049	CbGpPWpGaD
Donepezil—HRH3—nervous system—Gilles de la Tourette syndrome	0.00256	0.131	CbGeAlD
Donepezil—HRH3—central nervous system—Gilles de la Tourette syndrome	0.00246	0.126	CbGeAlD
Donepezil—HRH3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00199	0.0343	CbGpPWpGaD
Donepezil—HRH3—brain—Gilles de la Tourette syndrome	0.00196	0.1	CbGeAlD
Donepezil—ACHE—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00169	0.0291	CbGpPWpGaD
Donepezil—ACHE—midbrain—Gilles de la Tourette syndrome	0.00168	0.0861	CbGeAlD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00145	0.025	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00124	0.0213	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0012	0.0207	CbGpPWpGaD
Donepezil—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.00113	0.0578	CbGeAlD
Donepezil—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00112	0.0193	CbGpPWpGaD
Donepezil—ACHE—brain—Gilles de la Tourette syndrome	0.00106	0.0541	CbGeAlD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00104	0.0179	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00101	0.0174	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000942	0.0162	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000778	0.0134	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000756	0.013	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000722	0.0124	CbGpPWpGaD
Donepezil—SIGMAR1—brain—Gilles de la Tourette syndrome	0.00071	0.0363	CbGeAlD
Donepezil—HRH3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000704	0.0121	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000701	0.0121	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000653	0.0112	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000619	0.0106	CbGpPWpGaD
Donepezil—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000602	0.0308	CbGeAlD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000601	0.0103	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00056	0.00963	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000551	0.00947	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000534	0.00919	CbGpPWpGaD
Donepezil—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000495	0.0253	CbGeAlD
Donepezil—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000476	0.0244	CbGeAlD
Donepezil—HRH3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000471	0.00811	CbGpPWpGaD
Donepezil—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000458	0.0234	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000458	0.00787	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000458	0.00787	CbGpPWpGaD
Donepezil—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000451	0.0231	CbGeAlD
Donepezil—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000441	0.0226	CbGeAlD
Donepezil—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000434	0.0222	CbGeAlD
Donepezil—HRH3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000426	0.00733	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000392	0.00674	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00039	0.00671	CbGpPWpGaD
Donepezil—HTR2A—brain—Gilles de la Tourette syndrome	0.000378	0.0193	CbGeAlD
Donepezil—CYP2D6—brain—Gilles de la Tourette syndrome	0.000345	0.0176	CbGeAlD
Donepezil—ACHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000299	0.00514	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000299	0.00514	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000266	0.00458	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000259	0.00445	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000242	0.00416	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000241	0.00414	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000239	0.00411	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000235	0.00404	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000232	0.00399	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000219	0.00376	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000216	0.00372	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.000216	0.00372	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000205	0.00352	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000199	0.00342	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000185	0.00319	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000169	0.0029	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000156	0.00268	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000153	0.00264	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000151	0.00261	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000143	0.00246	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000141	0.00243	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000139	0.00239	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000129	0.00222	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.05e-05	0.00156	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	8.87e-05	0.00153	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.82e-05	0.00152	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	8.79e-05	0.00151	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.56e-05	0.00147	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.01e-05	0.00138	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.97e-05	0.00137	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.77e-05	0.00134	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.24e-05	0.00125	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	5.8e-05	0.000998	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.73e-05	0.000814	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.59e-05	0.00079	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.28e-05	0.000736	CbGpPWpGaD
